Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome--a single-centre experience and review of the literature.
about
Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitorsLow dose rapamycin exacerbates autoimmune experimental uveitisTherapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant PatientsHistological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.Sirolimus associated pneumonitis after nonmyeloablative peripheral blood stem cell transplant for sickle cell disease.Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection.Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future PerspectivesCT patterns of organizing pneumonia in patients treated with VEGF/mTOR inhibitors for metastatic renal cell cancer: an observational studyNoninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.Clinical application of mTORi based immunosuppression for renal transplantation in India.The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation.Adverse events associated with mTOR inhibitors.Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature.Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature.Sirolimus induced granulomatous interstitial pneumonitis.mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.Safety of mTOR inhibitors in adult solid organ transplantation.mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation.A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus.Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study.In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets.Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients.
P2860
Q26823023-E6C2DE63-D50E-4587-8ADF-EB3A9E310CF3Q28730115-C1721DD0-EA68-4FAA-9EC8-6EDBDDD442F6Q33432698-A0322420-DE7B-4177-8807-9179933A0BF7Q35935114-ED21AA7F-E113-4D7E-95C8-97FAAFEA020AQ36517807-D0F1AE8B-92D4-4C43-A729-F30955FB910BQ36864309-297011E9-436B-4070-81B8-10DB6194CADCQ37132788-D7992A09-A2F5-47BE-9504-04EB0FCB01B7Q37695529-06451201-A008-42A1-A0FE-62FB485690F1Q37701147-6901C736-3A40-4433-AA7C-4515BC8C0ABCQ37929851-8B02D52E-E18B-4106-828E-3FB4C0A08D6FQ38043510-56A6911E-7035-46F5-A931-06F15D7AD087Q38068519-0AFEB1F6-7D0D-48FA-B435-BBA9C840E629Q38187149-D5349853-AF13-4474-8BEE-310B53B202CCQ38237071-9D80A4AA-F91E-461B-96AA-35D56A131AD9Q38314899-8D8C431B-0B55-4CB5-B078-6C9A105846E3Q38510349-7CCFDABF-FBCD-4B48-8157-16F1799FC399Q38603164-22BD1606-4E2D-4F5E-99C4-B50DD708EE93Q38669190-9BCDC181-6C68-4F68-ABC2-494C74A5DE96Q38962103-640CE679-A164-4C59-ABCE-9FC1F5F5728FQ39024541-6F467A8E-90DA-4B6F-B58F-076A7F5A3A01Q41429996-FD2967B7-35AE-4A08-844E-6E843E9DC79AQ51749477-90971275-7F17-418F-A0F0-C6A6DB2467DDQ52314292-2EAB0A73-9120-4F9B-8DE4-41F935B5D43FQ53081112-A15E72D9-16E0-437A-9A4C-E7A18DE1ADCC
P2860
Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome--a single-centre experience and review of the literature.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pneumonitis associated with si ...... and review of the literature.
@en
type
label
Pneumonitis associated with si ...... and review of the literature.
@en
prefLabel
Pneumonitis associated with si ...... and review of the literature.
@en
P2093
P356
P1476
Pneumonitis associated with si ...... e and review of the literature
@en
P2093
Lars C Rump
Lorenz Sellin
Markus Flecken
Nikolaus J Buchner
Oliver Vonend
Peter Schenker
Stefan M Weiner
P304
P356
10.1093/NDT/GFM420
P407
P577
2007-07-04T00:00:00Z